BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
BAXTER INTERNATIONAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$24.99−0.29 (-1.15%)
Close on Oct 19, 2026
- Market cap
- $12.94B
- P/E (TTM)
- –
- Dividend yield
- 2.08%
Share price
+$1.90 (+8.23%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
BAXTER INTERNATIONAL INC grew revenue 5.4% to $11.47B over the twelve months to Jun 30, 2026. Free cash flow was $332.00M, down 42.1% from a year earlier.
Revenue
$11.47B
+5.4% vs. a year earlier
Operating income
-$274.00M
TTM Q2 2026
Free cash flow
$332.00M
-42.1% vs. a year earlier
EPS, diluted
-$2.09
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $12.94B
- P/E ratio
- –
- Price to sales
- 1.13
- Price to book
- 2.09
- Dividend yield
- 2.08%
- Free cash flow yield
- 2.56%
Fundamentals
- Revenue
- $11.47B
- Net income
- -$1.06B
- EPS, diluted
- -$2.09
- Free cash flow
- $332.00M
- Book value per share
- $11.98
- Diluted shares
- 518M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$11.47B+5.4% YoY
Gross profit
$3.45B-10.2% YoY
Operating income
-$274.00M
Net income
-$1.06B
EPS, diluted
-$2.09
Free cash flow
–
Reported periodTrailing twelve months